Sort   by:  
 Page size 
The phylogenetic divergence between parasitic and mammalian phosphoglycerate mutases (PGMs) offers an opportunity for selective pharmacologic targeting of glycolysis in disease-causing organisms. With this aim we previously described ipglycermides, discovered by affinity selection from a vast nuclei...
ORGANISM(S): Brugia malayi Dirofilaria immitis Escherichia coli Onchocerca volvulus Caenorhabditis elegans 
2021-04-06 | PXD024074 | Pride
Quantitative high-throughput screening (qHTS) pharmacologically evaluates libraries of drugs and investigational agents for potential therapeutic uses, toxicological risk assessment, and increasingly for academic chemical tool discovery. Phenotypic HTS assays aim to interrogate molecular pathways a...
ORGANISM(S): Caenorhabditis elegans 
2023-02-21 | PXD033552 | Pride
Sort   by:  
 Page size